Literature DB >> 28435834

Prevalence of HIV in a Prison of Tehran by Active Case Finding.

Seyed Ahmad Seyedalinaghi1, Behnam Farhoudi2, Minoo Mohraz1, Mona Mohammadi Firouzeh1, Mostafa Hosseini3, Kianoush Kamali4.   

Abstract

Entities:  

Year:  2017        PMID: 28435834      PMCID: PMC5395544     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


× No keyword cloud information.

Dear Editor-in-Chief

Prisoners worldwide, especially those with substance abuse, are at risk for acquiring HIV infection. Due to an insufficient supply of sterile needles and syringes in prisons, inmates are more inclined to share needles amongst themselves. A single needle is shared between 15 or 20 inmates. Some prisoners resort to making their own syringes with hardened plastic, resulting in damage to veins (1, 2). There is a correlation between homelessness and HIV among prisoners. Certain behavioral and demographic characteristics are related to HIV infection among the homeless, including low education level, substance abuse, and unprotected sex. Such high-risk behaviors and limited access to health care services and condoms increase their risk of HIV transmission (3). In Iran, prevalence of HIV infection is low among the general population and concentrated among injection drug users (IDUs) (4). Therefore, in order to prevent future HIV infections, both the general population and IDUs be educated on the risks of needle sharing. The establishment of treatment and prevention programs in prisons can also serve to limit HIV infection. Upon admission into prison, HIV screening can help detect undiagnosed prisoners. This will allow newly admitted prisoners to initiate antiretroviral therapy before the onset of fatal opportunistic infections. Controlling the virus at early stages can lead to a lower viral load and ultimately prevent HIV from spreading as effectively (5). We aimed to assess the prevalence of HIV on male prisoners in the Great Tehran Prison from Oct 2013 to May 2014 using the active case finding (ACF) strategy. The institutional review board of Tehran University of Medical Sciences approved the study. Active case finding of HIV was employed in the units by the prison’s clinical staff who educated the prisoners about HIV-related high-risk behaviors. All prisoners with risky behaviors were referred to the prison triangular clinic. Table 1 shows the frequency of HIV infection by rapid test in three units of the prison. Briefly, HIV prevalence in units of one, two and three of the prison based on the ACF were 1.2%, 1.3%, and 1.9%, respectively.
Table 1:

Description of active case findings for HIV in the units of the Great Tehran Prison

Unit of the prisonActive case finding (n)Released persons n (%)People who declined test n (%)All HIV+ patients n (%)
Unit 14964 (0.8)2 (0.4)6 (1.2)
Unit 255012 (2.2)3 (0.6)7 (1.3)
Unit 3 (bands) *69353 (7.7)2 (0.3)12 (1.9)
Unit 3 (admitted) *2050355 (17.3)149 (7.3)(3.2) 35

The first one is among who were present in the band and the second one (admission part) is among newly admitted prisoners.

Description of active case findings for HIV in the units of the Great Tehran Prison The first one is among who were present in the band and the second one (admission part) is among newly admitted prisoners. Of the estimated 10.2 million prisoners worldwide, found that 3.8% are HIV positive (6). In Estonia, up to 90% of inmates were HIV positive in 2004 (7). In some countries, HIV infection has been controlled among prison communities. For instances, HIV prevalence among inmates in Australia is near zero (6). Two huge outbreaks of HIV were reported in Iranian prisons. These outbreaks led to the development of new rules and policies to allow the introduction of needle exchange programs and widespread scale up of methadone treatment in prisons (8). HIV prevalence during admission time and annual rate of HIV were 24.4% and 16.8% (9). Prisons are a good environment to introduce ACF in order to detect HIV infection among prison admission in order to achieve higher coverage of HIV care and treatment services.
  5 in total

1.  HIV seroconversion among injection drug users in detention, Tehran, Iran.

Authors:  Mohammad R Jahani; Parastoo Kheirandish; Mostafa Hosseini; Hadi Shirzad; Seyed A Seyedalinaghi; Nazli Karami; Pegah Valiollahi; Minoo Mohraz; Willi McFarland
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

Review 2.  Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.

Authors:  Marziyeh Farnia; Bahman Ebrahimi; Ali Shams; Saman Zamani
Journal:  Int J Drug Policy       Date:  2010-04-21

Review 3.  Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.

Authors:  Kate Dolan; Andrea L Wirtz; Babak Moazen; Martial Ndeffo-Mbah; Alison Galvani; Stuart A Kinner; Ryan Courtney; Martin McKee; Joseph J Amon; Lisa Maher; Margaret Hellard; Chris Beyrer; Fredrick L Altice
Journal:  Lancet       Date:  2016-07-14       Impact factor: 79.321

4.  Prevalence of HIV infection and the correlates among homeless in Tehran, Iran.

Authors:  Abbas Ostad Taghi Zadeh; Seyedahmad SeyedAlinaghi; Farshad Fakhimi Hassanzad; Mehdi Hajizadeh; SeyedNajmeddin Mohamadi; Sahra Emamzadeh-Fard; Koosha Paydary; Mostafa Hosseini
Journal:  Asian Pac J Trop Biomed       Date:  2014-01

Review 5.  Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.

Authors:  Adeeba Kamarulzaman; Stewart E Reid; Amee Schwitters; Lucas Wiessing; Nabila El-Bassel; Kate Dolan; Babak Moazen; Andrea L Wirtz; Annette Verster; Frederick L Altice
Journal:  Lancet       Date:  2016-07-14       Impact factor: 79.321

  5 in total
  3 in total

Review 1.  HIV in Iran: onset, responses, and future directions.

Authors:  SeyedAhmad SeyedAlinaghi; Leila Taj; Elham Mazaheri-Tehrani; Sara Ahsani-Nasab; Negin Abedinzadeh; Willi McFarland; Minoo Mohraz; Ali Mirzazadeh
Journal:  AIDS       Date:  2021-03-15       Impact factor: 4.632

2.  The effect of a theory-based educational program on southern Iranian prisoners' HIV preventive behaviors: a quasi-experimental research.

Authors:  Zahra Hosseini; Pirdad Najafi; Shokrollah Mohseni; Teamur Aghamolaei; Sara Dadipoor
Journal:  BMC Public Health       Date:  2022-07-14       Impact factor: 4.135

3.  Estimating the Lifetime and Age-Conditional Risk of an HIV Diagnosis in Iran, 2011-2015.

Authors:  Maryam Nasirian; Marzieh Mahboobi; Mohammad Reza Maracy
Journal:  Iran J Public Health       Date:  2021-05       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.